2016 ADX
2016 ADX Banner

2016 Speakers

Gyorgy Abel, M.D., Ph.D., Director, Molecular Diagnostics, Immunology & Clinical Chemistry, Laboratory Medicine, Lahey Hospital & Medical Center

Alex J. Adams, Pharm.D., MPH, Executive Director, Idaho State Board of Pharmacy

Ray Ahmed, Marketing Manager, Sales and Marketing, OraSure Technologies, Inc.

Catherine Alix-Panabières, Ph.D., Director, Laboratory of Rare Human Circulating Cells (LCCRH), Cellular and Tissular Biopathology of Cancers, University Medical Center of Montpellier

Alison L. Allan, Ph.D., Senior Oncology Scientist & Assoc Professor, Oncology & Anatomy & Cell Biology, London Regional Cancer Center

Hooman Allayee, Ph.D., Associate Professor, Preventive Medicine, University of Southern California, Keck School of Medicine

Patrice Allibert, Ph.D., CEO, Management, GenePOC

Karen Anderson, M.D., Ph.D., Associate Professor, School of Life Sciences, Biodesign Institute, Arizona State University

Maria Arcila, Ph.D., Director, Diagnostic Molecular Pathology Laboratory, Associate Attending Pathologist, Memorial Sloan Kettering Cancer Center

D. Randall Armant, Professor, Obstetrics & Gynecology, Wayne State University School of Medicine

Nicholas G. Assad, Senior Vice President, Business Development, CirrusMD, Inc.

Edina Avdic, Pharm.D., MBA, BCPS, AQ-ID, Clinical Specialist, Infectious Diseases; Associate Director, Antimicrobial Stewardship Program, Pharmacy, John Hopkins Medicine

Till T. Bachmann, Ph.D., Reader, Personalized Medicine in Infectious Disease; Deputy Head, Division of Infection and Pathway Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh

Mike Barlow, Vice President, Operations, MolDX Executive Lead, Specialty Contracts, Palmetto GBA

J. Carl Barrett, Ph.D., Vice President, Translational Sciences, Onc iMed, AstraZeneca

Keith Batchelder, M.D., CEO & Founder, Genomic Healthcare Strategies

Pinar Bayrak-Toydemir, M.D., Ph.D., FACMG, Associate Professor, Pathology, University of Utah; Medical Director, Molecular Genetics and Genomics, ARUP Laboratories

Anne Beall, Director, U.S. Clinical Marketing; Microbiology & Molecular Solutions, BioMerieux Inc.

Lora J. H. Bean, Ph.D., Assistant Professor, Human Genetics, Emory University

Arthur L. Beaudet, M.D., Professor, Molecular & Human Genetics, Baylor College of Medicine; Consultant, Baylor Miraca Genetic Labs

Holger Becker, Ph.D., Founder & CSO, microfluidic ChipShop GmbH

John Beeler, Ph.D., Vice President, Business Development, Inivata

Jeffrey Benabio, Director, Healthcare Transformation, Kaiser Permanente

Peter Benn, Professor, Genetics and Genome Sciences, University of Connecticut Health Center

Scott M. Berry, Ph.D., Associate Scientist, Biomedical Engineering, University of Wisconsin, Madison

David Bick, M.D., CMO & Faculty Investigator, HudsonAlpha Institute for Biotechnology; Founder & CMO, Envision Genomics

Farideh Bischoff, Ph.D., Executive Director, Scientific Affairs; Head, Clinical Development Lab, Menarini Silicon Biosystems

Carol Blackford, Acting Deputy Director, Hospital and Ambulatory Policy Group, Center for Medicare, Centers for Medicare and Medicaid Services

Mark Blatt, (former) Worldwide Medical Director, Intel Corporation; Mark Blatt Associates, Inc.

Francine B. Blumental de Abreu, Ph.D., Genomic Analyst, Laboratory for Clinical Genomics and Advanced Technology (CGAT), Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center

Mark S. Boguski, M.D., Ph.D., Founder & CMO, Precision Medicine Network, Inc.

Darrell Borger, Ph.D., Director, MGH Biomarker/Translational Research Laboratory, Cancer Center, Massachusetts General Hospital

Alice Borrelli, Director, Global Health and Workforce Policy, Intel

Ihor Boszko, Vice President, Business Development, Xagenic, Inc.

Joseph M. Campos, Ph.D., D(ABMM), F(AAM), Interim Chief, Division of Laboratory Medicine; Director, Microbiology Laboratory, Molecular Diagnostics Laboratory, and Laboratory Informatics; Children’s National Medical Center; Professor, Departments of Pediatrics, Pathology, and Microbiology/Immunology/Tropical Medicine; George Washington University Medical Center

Brian P. Carey, Partner, Foley Hoag LLP

Anders Carlsson, Ph.D., David and Dana Dornsife, College of Letters, Arts and Sciences, University of Southern California

Patricia Carrigan, Ph.D., Global Head, Translational Assays Technologies, Bayer HealthCare Pharmaceuticals

Eli Casdin, Managing Member, Casdin Capital

Lon Castle, M.D., CMO, Molecular Genetics And Personalized Medicine, Evicore Healthcare

John Chiang, Ph.D., Director, Casey Eye Institute, Oregon Health & Science University

Charles Chiu, M.D., Ph.D., Associate Professor, Lab Medicine and Infectious Diseases; Director, Abbott Viral Diagnostics and Discovery Center; Associate Director, Clinical Microbiology Laboratory, University California, San Francisco

Wendy Chung, M.D., Ph.D., Kennedy Family Associate Professor of Pediatrics and Medicine, Director of Clinical Genetics, Columbia University

Mirza Cifric, CEO, Veritas Genetics

Melina Cimler, Ph.D., Senior Vice President, Quality & Regulatory, Adaptive Biotechnologies

John Clarkson, Chief Executive, Atlas Genetics

Peter Collins, CCO, Premaitha Health

Rita Colwell, Ph.D., Distinguished Professor, Department of Cell Biology & Molecular Genetics, College of Computer, Mathematical, & Natural Sciences, University of Maryland

Barbara A. Conley, M.D., Associate Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute

Chris Connelly, Ph.D., Research & Development, Scientific Manager, Molecular Technology, Streck

Jerry Conway, Vice President, Payer Relations & Reimbursement, Foundation Medicine, Inc.

Richard S. Cooper, Member, McDonald Hopkins LLC

Robert Daber, Ph.D., Vice President, Genomics Operations and Development, Laboratory Medicine, Bio Reference Laboratories

Daniel Danila, M.D., Genitourinary Oncology Service, Medicine, Memorial Sloan-Kettering Cancer Center

Dwight Denham, Vice President, Global Health Economics & Reimbursement, Danaher Corp

Vanessa DePalma, Senior Corporate Director, Health Plan and Payer Markets, Meridian Bioscience, Inc.

Allison M. Dering-Anderson, BA, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy, University of Nebraska College of Pharmacy

Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Maximilian Diehn, M.D., Ph.D., Assistant Professor, Radiation Oncology, Stanford Cancer Institute, Institute for Stem Cell Biology & Regenerative Medicine, Stanford University

Marisa Dolled-Filhart, Ph.D., Director, Pathology and Companion Diagnostics, Translational Biomarkers, Merck & Co., Inc.

Robert M. Dorazio, Research Statistician, Biological Resources Division, United States Geological Survey

David J. Ecker, Ph.D., Divisional Vice President and Carlsbad Site General Manager, Ibis Biosciences Inc., an Abbott Company

Laura Elnitski, Ph.D., Principal Investigator, Translational and Functional Genomics Branch, National Human Genome Research Institute

Garth D. Ehrlich, Ph.D., FAAAS, Professor, Microbiology and Immunology, Otolaryngology Head and Neck Surgery, Drexel University College of Medicine

Kenneth Emancipator, M.D., Executive Medical Director, Head of Companion Diagnostics, Merck Research Laboratories

Joshua Evans, HERA Lab Planners

Navid Farahani, M.D., Pathology, Informatics, University of Pittsburgh Medical Center

Dana Farengo Clark, M.S., Genetic Counselor, Oncology Program, University of Pennsylvania

W. Andrew Faucett, Professor, Genomic Medicine, Geisinger Health System

Lauren Feldman, M.H.A., Associate Director, ADVI Health

Helen Fernandes, Ph.D., Pathology & Laboratory Medicine, Weill Cornell Medical College

Joseph Ferrara, President, Boston Healthcare

Andrea Ferreira-Gonzalez, Ph.D., Chair, Molecular Diagnostics Division, Pathology, Virginia Commonwealth University Medical School

Kyle Fetter, AVP, Advanced Diagnostics Services, XIFIN, Inc.

Thomas M. File, Jr., M.D., MSc, MACP, FIDSA, FCCP, Chair, Infectious Disease Division Summa Health System Akron; Professor, Internal Medicine, Northeast Ohio Medical University (NEOMED)

Andrew C. Fish, J.D., Executive Director, AdvaMedDx

Albert Folch, Ph.D., Associate Professor, Bioengineering, University of Washington

Orazio Fortunato, Ph.D., Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori

Jason Franasiak, M.D., FACOG, Attending Physician, Reproductive Medicine Associates of New Jersey, Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers University, Reproductive Endocrinology and Infertility, Robert Wood Johnson Medical School

Charlotte A. Gaydos, MS, MPH, DrPH, Professor, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University

Georg K. Gerber, M.D., Ph.D., MPH, Assistant Professor of Pathology, Harvard Medical School; Co-Director, Center for Clinical and Translation Metagenomics, Director, Computational Unit, Associate Pathologist, Department of Pathology, Brigham and Women’s Hospital

Steven Gerst, M.D., MBA, MPH, CHE, CMO, ARC Devices Limited

Soma Ghosh, Ph.D., Regulatory Scientist, Division of Molecular Genetics and Pathology, OIR, CDRH, FDA

Geoffrey T. Gibney, M.D., Georgetown-Lombardi Comprehensive Cancer Center

Eric van Gieson, Ph.D., R&D Director, Diagnostics and Biosurveillance, MRIGlobal

Jason L Gillman, MSPH, Director, Cancer Genomics, Intermountain Healthcare

Alexis S. Gilroy, Partner, Digital Health & HIT, Jones Day

Harry Glorikian, Healthcare Consultant

Debra Goff, Pharm.D., FCCP Infectious Disease Specialist,The Ohio State University Wexner Medical Center

James Goldberg, MD, Chief Medical Officer, Counsyl

Myla Lai-Goldman, M.D., CEO, GeneCentric Diagnostics, Inc.

Anthony R. Gregg, MD, FACOG, FACMG, B.L. Stalnaker Professor, Director, Division of Maternal Fetal Medicine, Director, Obstetrics - UF Health Shands, University of Florida College of Medicine

Catherine M. Grgicak, Ph.D., Assistant Professor, Program in Biomedical Forensic Sciences, Boston University School of Medicine

John Griffith, Ph.D., Principal Scientist, Southern California Coastal Water Research Project

Wayne W. Grody, M.D., Ph.D., Professor, Medical Genetics and Molecular Pathology, Pathology & Lab Medicine, Pediatrics, and Human Genetics; Director, Molecular Diagnostic Laboratories and Clinical Genomics Center, University of Calfornia Los Angeles School of Medicine

Daniel S. Grosu, MD, MBA, CMO, Clinical and Medical Affairs, Sequenom, Inc.

James L. Gulley, M.D., Ph.D., Chief, Genitourinary Malignancies Branch, Director, Medical Oncology Service, Center for Cancer Research, NCI, NIH

Michael Haffner, M.D., Carbone Cancer Center, University of Wisconsin

Daniel Halevy, MD FASN, Medical Director II, Horizon Blue Cross Blue Shield

Tobias Hampshire, Ph.D., Global Product Manager, ParaDNA, Science & Innovation, LGC

Sam M. Hanash, M.D., Ph.D., Professor, Molecular Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center

Tuan Ha-Ngoc, Executive Chairman, Kew Group

John Hanna, Vice President, Endocrinology, Veracyte, Inc.

Erol Harvey, Ph.D., CEO, MiniFAB

Nur Hasan, Ph.D., Adjust Faculty, Center for Bioinformatics and Computational Biology, University of Maryland College Park, Leader Science Team, CosmosID

David Haslam, M.D., Associate Professor, Pediatrics, Cincinnati Children’s Hospital Medical Center

Christos Hatzis, PhD, Assistant Professor, Medicine; Director, Bioinformatics, Breast Medical Oncology, Yale Comprehensive Cancer Center, Yale School of Medicine

Hua-Jun He, Ph.D., Research Biologist, Biosystems and Biomaterials Division, National Institute of Standards and Technology

Karen A. Heichman, Ph.D., Vice President, New Technology Assessment and Licensing Director, Pharmadx Program ARUP Laboratories, Inc.; Adjunct Associate Professor of Pathology, University of Utah School of Medicine

Daniel Helbling, Senior Clinical Genomics Analyst, Human Molecular Genetics Center, Medical College of Wisconsin

Michael J. Heller, Ph.D., Professor, Bioengineering & Nanoengineering, University of California San Diego

Manuel Hernandez, M.D., Principal & Health Practice Leader, CannonDesign

Suzanne Higginbotham, Pharm.D., BCACP, Director, Center for Pharmacy Care; Director, Residency Programs, Duquesne University Mylan School of Pharmacy

Sarah Highlander, Professor, Genomic Medicine, J. Craig Venter Institute

Lee Hilborne, M.D., Professor, Pathology and Laboratory Medicine, University California, Los Angeles; Medical Director, Quest Diagnostics, Southern California; Deputy Director for Global Health, RAND Corporation

Kenneth C. Hohmeier, Pharm.D., Director, Community Affairs, Assistant Professor, Clinical Pharmacy, University of Tennessee Health Science Center

David S. B. Hoon, Ph.D., MSc, Chief of Scientific Intelligence, Director, Molecular Oncology, Director, JWCI Sequencing Center, John Wayne Cancer Institute

Laurie Howard, Vice President, Reimbursement, Labcorp

Eric Huang, Ph.D., Professor, Dermatology, University of California, San Diego

Shuguang Huang, Ph.D., Associate Vice President, Biostatistics, Helomics

Claire Huguet, Ph.D., Head, Biomarker Services, Biosciences, Randox Biosciences

Ted R. Hunt, Chief Trial Attorney, Prosecuting Attorney’s Office, Jackson County (Kansas City, Missouri)

Hatim Husain, M.D., Physician, Medical Oncology, University of California, San Diego

Karen L. Huyck, M.D., Ph.D., Assistant Professor, Occupational and Environmental Medicine, Geisel School of Medicine, Dartmouth College

Filip Janku, M.D., Ph.D., Assistant Professor, Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center

Gulnaz Javan, Ph.D., Vice-Chair, Institutional Review Board; Assistant Professor, Forensic Science Program, Department of Physical Sciences, Alabama State University

Francois Jean, Ph.D., Associate Professor, Microbiology and Immunology; Scientific Director, Facility for Infectious Disease and Epidemic Research (FINDER), University of British Columbia

Elaine Jeter, M.D., Contractor & Medical Director, Palmetto GBA LLC

Steven Kafka, Ph.D., President and COO Management, Foundation Medicine

Rashmi Kanagal-Shamanna, M.D., Assistant Professor, Hematopathology, Molecular Pathologist, MD Anderson Cancer Center

Jing X. Kang, M.D., Ph.D., Associate Professor of Medicine, Harvard Medical School, Director, Laboratory for Lipid Medicine and Technology

Shana Kelley, Ph.D., Professor, Biochemistry, University of Toronto, Founder & CTO, Xagenic Inc.

Jennifer Kerr, Ph.D., Assistant Professor, Biology, Oral Microbiology, Notre Dame Maryland University

Young Kim, Ph.D., Lead Application Scientist, Research & Development, Seegene Technologies

Roger D. Klein, M.D., J.D., Medical Director, Molecular Oncology, Cleveland Clinic Foundation

Donald Klepser, Ph.D., MBA, Associate Professor, Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center

Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy

Dan Knights, Assistant Professor, Computer Science and Engineering, Biotechnology Institute, University of Minnesota

Isaac Kohane, M.D., Ph.D., Lawrence J. Henderson Professor of Pediatrics; Chair, Boston Children’s Hospital Informatics Program; Co-Director, Center for Biomedical Informatics, Lawrence J. Henderson Professor, Pediatrics and Health Sciences and Technology, Harvard Medical School

Martin Kohlmeier, M.D., Ph.D., Research Professor, Department of Nutrition, UNC Schools of Medicine and Public Health, Chapel Hill, and Nutrigenetics Laboratory, UNC Nutrition Research Institute

Scott Kopetz, M.D., Ph.D., FACP, Associate Professor, Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center

Jason Kralj, Ph.D., Staff Scientist, Complex Microbial Systems Group, Biosystems and Biomaterials Division, Material Measurements Laboratory, NIST

Raj Krishnan, Ph.D., CEO, Biological Dynamics

Shashi Kulkarni, MS, Ph.D., Vice Chairman, Research, Molecular and Human Genetics, Baylor College of Medicine Houston Texas; Chief Scientific Officer, Baylor Miraca Genetics Laboratory

Nathaniel Lacktman, Partner, Telemedicine and Virtual Care Practice, Foley & Larnder

Eric Lai, Ph.D., Senior Vice President and Head, Pharmacogenomics, Companion Diagnostics, Takeda Development Centers of America

Joshua M. Lang, M.D., MS, Assistant Professor, Medicine, Carbone Cancer Center, University of Wisconsin

Andrea H. Lauber, Ph.D., Executive Director, Business Development, Clinical Biomarkers and Pharmacodiagnostics, Bristol-Myers Squibb

David Layton, Improvement Engineering and Operations Leader, ARUP Laboratories

Matthew Lebo, Ph.D., FACMG, Director, Bioinformatics, Partners Personalized Medicine; Instructor, Pathology, Brigham and Women’s

Roger V. Lebo, Ph.D., FACMG, Professor Emeritus, Pathology, Northeast Ohio Medical University

Nathan A. Ledeboer, Ph.D., Associate Professor of Pathology, Medical Director, Clinical Microbiology, Medical College of Wisconsin

Eunice Lee, Ph.D., Chief, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, US Food and Drug Administration

Ben Legendre, Jr., Vice President, Laboratory Operations, Transgenomic, Inc.

Jason Lih, Ph.D., Principal Scientist, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Kent Lohman, Ph.D., MRIGlobal

Ira M. Lubin, Ph.D., FACMG , Branch Chief (acting); Team Lead, Genetics, Laboratory Research and Evaluation Branch, Division of Laboratory Systems/CSELS, Office of Public Health Scientific Service, Centers for Disease Control and Prevention

Patricia Macholan, Executive Director, Laboratory Technical Operations Excellence, Quest Diagnostics (IEG) a Laboratory of the Future

G. Mike Makrigiorgos, Ph.D., Professor, Radiation Oncology, Dana-Farber and Harvard Medical School

Dipankar Manna, Ph.D., Principal Scientist, LucigenDx

Elizabeth A. Mansfield, Ph.D., Director, Personalized Medicine, Office of In Vitro Diagnostics & Radiological Health, FDA CDRH

Rong Mao, M.D., Associate Professor, Pathology, University of Utah; Medical Director, Molecular Genetics and Genomics, ARUP Laboratories

Dario Marchetti, Ph.D., Director, Center of the Biomarker Research Program, The Methodist Hospital Research Institute

Ron L. Martin, Founder and President, Nutrigenetics Unlimited, Inc.

Charles Mathews, Vice President, Boston Healthcare

Christoph Mauracher, Ph.D., Managing Director, Sony DADC BioSciences GmbH

Donald May, Executive Vice President, Payment & Health Care Delivery Policy, AdvaMed

Ron Mazumder, Ph.D., MBA, Global Head, R&D and Operations, Janssen Diagnostics, Janssen Pharmaceutical Companies of Johnson & Johnson

David McClintock, M.D., Medical Director, Pathology Informatics, Pathology, The University of Chicago Medicine

Rebecca McClure, M.D., Senior Scientist, Pathology, Health Sciences North/Horizon Santé-Nord

Bruce R. McCord, Ph.D., Professor, Analytical/Forensic Chemistry, Florida International University

Timothy P. McMahon, Ph.D., Deputy Director of Forensic Services; Contractor; ARP Sciences LLC, a Division of ARP Supporting the Armed Forces Medical Examiner System

Karen Meaburn, Ph.D., Research Scientist, NCI, NIH

Dan McPeak, Ph.D., Director, Microfluidics, Ativa Medical

Timothy D. Minogue, Ph.D., Chief, Molecular Diagnostics Department, Diagnostic Systems Division, USAMRIID

Susan Mockus, Ph.D., Manager, Clinical Analytics & Curation, The Jackson Laboratory for Genomic Medicine

William Morris, CMIO, Cleveland Clinic

Jennifer Morrissette, Ph.D., Scientific Director, Clinical Cytogenetics Laboratory, Clinical Director, Center for Personalized Diagnostics (CPD), University of Pennsylvania School of Medicine

Pamela N. Munster, M.D., Professor, Medicine; Program Leader, Development Therapeutics; Director, Early Phase Clinical Trials’ Program, Helen Diller Cancer Center, University of California, San Francisco

Anuradha Murali, Ph.D., MSCR, Clinical Trial Manager, Gastroenterology Associates of Orangeburg

Muhammed Murtaza, Ph.D., MBBS. Assistant Professor and Co-Director, Center for Noninvasive Diagnostics, Translational Genomics Research Institute

Chris Myatt, CEO, MBio Diagnostics, Inc.

Dave Nellesen, Ph.D., Vice President, Analysis Group

Mark E. Nunes, M.D., Associate Professor, Pediatrics, Division Chief, Medical Genetics, Kaiser Permanente

John J. O’Leary, M.D., Ph.D., MSc, MA, FRCPath, FFPathRCPI, Chair, Pathology, Trinity College Dublin; Director, Pathology, Coombe Women and Infants University Hospital; Consultant, Pathologist, St. James’s Hospital; Principal Investigator, Biomedical Diagnostics Institute (BDI)

Payam Pakravan, Vice President, Strategy & Planning, OTN (Ontario Telemedicine Network)

Alex Parker, Ph.D., Vice President, Business Development at Foundation Medicine

Sonya Parpart-Li, Ph.D., Associate Scientist, Personal Genome Diagnostics

Michael Parks, Ph.D., Developmental Scientist, Regional Genetics, Birmingham Women’s NHS Foundation Trust

Bruce Patterson, MD, CEO, Executive, IncellDx

Rosanna Peeling, Ph.D., Professor and Chair, Diagnostics Research, Clinical Research, ITD, London School of Hygiene & Tropical Medicine

Maureen Peterson, Ph.D., Product Development Scientist, Research & Development, NuGEN Technologies

William Pignato, Founder and Principal, W.J. Pignato & Associates, LLC

Jamie Platt, Ph.D., Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.

Vincent M. Purpero, Ph.D., Forensic Scientist and Senior DNA Analyst, Wisconsin State Crime Laboratory, Division of Law Enforcement Services, Wisconsin Department of Justice

Girish Putcha, M.D., Ph.D., Director, Laboratory Science, Palmetto GBA (MolDX)

Bruce Quinn, M.D., Ph.D., Senior Director, FaegreBD Consulting

Matthew Quinn, MBA, East Coast Managing Director, Healthcare and Life Sciences, Intel Corporation

Gail Radcliffe, President, Consulting, Radcliffe Consulting, Inc.

Mitch Raponi, Ph.D., Senior Director, Molecular Diagnostics, Clovis Oncology

Divyaa Ravishankar, MS, Senior Consultant, Life Sciences, Frost & Sullivan

Victoria M. Raymond, Adjunct Clinical Assistant Professor, Licensed Certified Genetic Counselor, Cancer Genetics Clinic, University of Michigan Health System

Svetlana Rechitsky, Ph.D., Laboratory Director, Reproductive Genetics Innovations

Andrew D. Rhim, M.D., Assistant Professor, Internal Medicine, Division of Gastroenterology, University of Michigan

Nadeem Riaz, M.D., Radiation Oncology, Memorial Sloan Kettering Cancer Center

Julie A. Ribes, M.D., Ph.D., Director, Clinical Microbiology, Associate Director, Hospital Laboratories, UK HealthCare Chandler Hospital

Greg Richard, Senior Vice President, Commercial Services, Interpace Diagnostics

Victoria Rimkunas, Ph.D., Head, Integrated Diagnostics Lab, Merrimack Pharmaceuticals

David L. Rimm, M.D., Ph.D., Professor, Pathology, Yale University

Joseph Ring, MS, DNA Analyst, Emerging Technology Section-AFDIL, Contractor; ARP Sciences LLC a Division of ARP, Supporting the Armed Forces Medical Examiner System

Michael H. A. Roehrl, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

Gerrit van Roekel, MSc, MBA, Senior Program Officer, Life Science Partnerships, The Bill and Melinda Gates Foundation

Erica Romsos, MFS, Forensic Scientist, Biomolecular Measurement Division, Applied Genetics, NIST

Donna Roscoe, Ph. D., Branch Chief, Molecular Genetics Branch, Division of Molecular Genetics and Pathology, Office of In Vitro Diagnostics, CDRH, FDA

Mark Roschewski, M.D., Staff Clinician, Commissioned Corps, United States Public Health Service, Center for Cancer Research, Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health

Jonathan Roy, Vice President Pharma Partnerships, Leica Biosystems

Salvatore Salamone, Ph.D., President and CEO, Saladax Biomedical, Inc.

Avni B. Santani, Ph.D., Director, Genomic Diagnostics, Pathology and Lab Medicine, The Children’s Hospital of Philadelphia

Alexander Sbordone, Manager, Operations, MinuteClinic, CVS Health

Aaron J. Schetter, Ph.D., MPH, Senior Staff Fellow, Division of Molecular Genetics and Pathology/OIR, Center for Devices and Radiological Health, U.S. Food and Drug Administration

Ted E. Schutzbank, Ph.D., D(ABMM), Technical Director, Specialized Testing and Microbiology, Laboratory Services, St. John Providence Health System

Peter A. Schweitzer, Ph.D., Director, Genomics Facility, Institute of Biotechnology, Cornell University

Sarah Scollon, MS, C.G.C., Instructor, Pediatrics-Oncology, Baylor College of Medicine

Sid Scudder, M.D., Senior Director, Clinical Science, Genomics & Oncology, Roche Molecular Systems

Xueying Sharon Liang, M.D., Ph.D., Regulatory Scientist, Division of Molecular Genetics and Pathology, OIR/CDRH/FDA

Bret Shillingstad, M.D., CMIO, Epic

Stephanie Shulman, M.P.H., M.S., M.T. (ASCP), Director, Clinical Laboratory Evaluation Program, Wadsworth Center, New York State Department of Health

Jeff Shulkin, M.S., Principal, Morph Design, Inc.

Heike Sichtig, Ph.D., Medical Countermeasures / Multiplex, Microbiology Devices, Center for Devices (CDRH), FDA

Vahan Simonyan, Ph.D., Lead Scientist, Director, Bioinformatics; Principal Investigator, HIVE, Food and Drug Administration (FDA)

Veena Singh, Medical Director, Biocept

Rashmi Sinha, Senior Investigator, Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute

Per Skoglund, Change Manager, Karolinska University Laboratory, Karolinska University Hospital

Tom Slezak, Distinguished Member of the Technical Staff, Pathogen Bioinformatics, Lawrence Livermore National Laboratory

Dan Snyder, President & CEO, MolecularMD

Sneha Somasekar, Staff Research Associate, Viral Diagnostics and Discovery Center, Laboratory Medicine, University of California San Francisco

Stephen S. “Sky” Soom, Associate Vice President, Performance & Innovation, PAML

Lynn Sorbara, Ph.D., Program Director, Cancer Biomarkers Research Group, NIH/NCI/Division of Cancer Prevention

Barbara A. Spitz, AIA, HERA Lab Planners

Roberto Spricigo, Manager, Strategic Alliances & OEM, PON, QIAGEN Lake Constance

Glenn D. Steele, Jr., M.D., Ph.D., Chairman of the Board & Chief, Corporate Strategy, xG Health Solutions, Inc.

Ester Stein, Director, Corporate Reimbursement, Abbott Molecular

Steve Steinhubl, M.D., Director, Digital Medicine, Scripps Translational Science Institute; Cardiologist, Scripps Clinic

Tilak K. Sundaresan, Instructor, Medicine, Massachusetts General Hospital Cancer Center

Pamela Swatkowski, Director, Global Regulatory Affairs, Abbott Molecular

Timothy E. Sweeney, M.D., Ph.D., Research Associate, Institute for Immunity, Transplantation and Infections, Stanford University

Janis M. Taube, M.D., MSc, Director, Dermatopathology; Associate Professor, Dermatology and Pathology, Johns Hopkins University School of Medicine

Živana Težak, Ph.D., Associate Director, Science and Technology, Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD), Center for Devices and Radiological Health (CDRH), FDA

Alain R. Thierry, M.D., Director, Research, Research Institute in Oncology of Montpellier, INSERM

Tom Tisone, CEO, BioDot, Inc.

Nathan Treff, Director, Molecular Biology Research, Reproductive Medicine Associates of New Jersey; Associate Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers-Robert Wood Johnson Medical School; Adjunct Faculty Member, Department of Genetics, Rutgers-The State University of New Jersey

Sylvia J. Trujillo, Senior Washington Counsel, American Medical Association (AMA)

Ephraim L. Tsalik, M.D., Ph.D., Assistant Professor, Medicine, Duke University School of Medicine

Sean Tunis, CEO, Center for Medical Technology Policy

Katherine Tynan, Ph.D., President, Tynan Consulting LLC

Abraham Tzou, M.D., Medical Officer, Center for Devices and Radiological Health, Food and Drug Adminstration

Mark Umbarger, Ph.D., Director, Research and Development, Good Start Genetics

Willy Valdivia, CEO, Orion Integrated Biosciences, Inc.

Ignatia B. Van den Veyver, Professor, OB-GYN and Molecular Human Genetics, Baylor College of Medicine

Peter Vandenberghe, M.D., Ph.D., Head, Laboratory for the Cytogenetic and Molecular Diagnosis of Malignant Diseases, Center for Human Genetics, University Hospitals Leuven; Professor, Medicine, Human Genetics, KU Leuven

George Vasmatzis, Ph.D., Director, Biomarker Discovery Program, Center for Individualized Medicine, Mayo Clinic

Victor Velculescu, M.D., Ph.D., Professor, Oncology; Co-Director, Cancer Biology, Johns Hopkins Sidney Kimmel Cancer Center; Co-Founder, Personal Genome Diagnostics

Werner Verbiest, Global Head Janssen Diagnostics

Erik Viirre, M.D., Ph.D., Adjunct Professor, UCSD Departments of Neurosciences, Surgery and Cognitive Sciences, Arthur C. Clarke Center and XPRIZE Foundation

Steve Vitale, Managing Director, Diaceutics AIS, Diaceutics Group

Karl V. Voelkerding, M.D., Professor, Pathology, University of Utah; Medical Director for Genomics and Bioinformatics, ARUP Laboratories

Guiqing Wang, M.D., Ph.D., Chief of Labs, Pathology and Clinical Laboratories, Westchester Medical Center & New York Medical College

Yixin Wang, Ph.D., CSO, Celsee Diagnostics

Scott Waniger, Vice President, BioServices Division, Cell Culture Company

Ronald J. Wapner, M.D., Professor, Obstetrics and Gynecology, Vice Chair, Research, Director, Reproductive Genetics, Columbia University Medical Center

Alexander W. Wyatt, Ph.D., Senior Research Scientist, Vancouver Prostate Centre, Assistant Professor, University of British Columbia

Karen Weck, M.D., Professor, Pathology & Laboratory Medicine and Genetics, University of North Carolina, Chapel Hill

Bernard H. Weigl, Ph.D., Principal Investigator, Flow Based Diagnostics, Intellectual Ventures Management LLC

Daniel Wetterskog, Ph.D., Senior Scientific Officer, Centre for Evolution and Cancer, Translational Biology of Urological Cancers Team, Institute of Cancer Research

Alexandra Whale, Ph.D., Senior Researcher, Molecular and Cell Biology Team, Science and Innovation Division, LGC Group

Myra L. Wilkerson, M.D., Vice Chair, Laboratory Medicine Service Line, Geisinger Health System

P. Mickey Williams, Ph.D., Director, Molecular Characterization & Clinical Assay Development Laboratory (MoCha), Frederick National Laboratory for Cancer Research

Mark Wilson, Ph.D., Research Leader, Applied Genomics, Battelle Memorial Institute

Emily Winn-Deen, Ph.D., Chief Strategy Officer, Mesa Biotech, Inc.

Rina Wolf, Vice President, Commercialization Strategies, Consulting & Industry Affairs, XIFIN, Inc.

Lawrence J. Worden, Vice President and Senior Partner, Market Diagnostics International

C.-Ting Wu, Ph.D., Professor, Genetics, Harvard Medical School

Svetlana Yatsenki, Associate Director, Clinical Genomics Labs, Obstetrics, Gynecology, & Reproductive Sciences, University of Pittsburgh, School of Medicine

Ming Yu, Ph. D., Staff Scientist, Clinical Research, Fred Hutchinson Cancer Center

Rick Zimmerer, Partner, Life Sciences Advisory Services, KPMG LLP

Rebekah Zimmerman, Ph.D., Laboratory Director, Clinical Genetics, Foundation for Embryonic Competence

Justin Zook, National Institute of Standards and Technology

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Register Online

2016 Brochure

2016 Next Generation Dx Summit Brochure

ADX 2016 CAG Brochure Icon

Premier Sponsors


Positive ID

Precision for Medicine 

View All Sponsors

View Media Partners

Media Gallery Thumb

Related Products